| Predicate |
Object |
| contentType |
Comment|Letter |
| issn |
0028-2162 |
| issueIdentifier |
9 |
| pageRange |
498; author reply 498- |
| publicationName |
Nederlands tijdschrift voor geneeskunde |
| startingPage |
498; author reply 498 |
| bibliographicCitation |
Hoefnagels WA. [Antithrombotic therapy after myocardial infarction: arguments for the use of acetylsalicylic acid and coumarin derivatives]. Ned Tijdschr Geneeskd. 2005 Feb 26;149(9):498; author reply 498. PMID: 15771351. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_260c7f80c470daed5a01b9e6c1ccea0d |
| date |
2005-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/15771351 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0028-2162
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6028 |
| language |
Dutch |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
[Antithrombotic therapy after myocardial infarction: arguments for the use of acetylsalicylic acid and coumarin derivatives] |
| discusses |
http://id.nlm.nih.gov/mesh/M0005258
http://id.nlm.nih.gov/mesh/M0008434
http://id.nlm.nih.gov/mesh/M0017012 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D005343Q000627
http://id.nlm.nih.gov/mesh/D009203Q000517
http://id.nlm.nih.gov/mesh/D003374Q000627
http://id.nlm.nih.gov/mesh/D010975Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D006801 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID323 |